(Q40897930)

English

Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

0 references

author name string

Nicol A

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Nieda M

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Koezuka Y

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Porcelli S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Suzuki K

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Tadokoro K

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Durrant S

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Juji T

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

229-234

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Natural killer cell proliferation induced by anti-NK1.1 and IL-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Signalling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Phenotypic and functional analysis of CD4+ NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

The CD1 family: a third lineage of antigen-presenting molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327139

14 September 2018

Role of TCR V alpha 24 J alpha Q+ T cells in autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10692041

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2567.2000.00952.X

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40897930&oldid=1909883470"